talactoferrin alfa has been researched along with Local Neoplasm Recurrence in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Excerpt | Relevance | Reference |
---|---|---|
"Talactoferrin alfa (TLF) is a unique recombinant form of human lactoferrin." | 1.40 | Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients. ( Bhattacharya, N; Blenman, KR; Engleman, E; Hwang, G; Lee, PP; Malik, R; Neal, JW; Pultar, P; Riess, JW; San-Pedro Salcedo, M; Wakelee, HA, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riess, JW | 1 |
Bhattacharya, N | 1 |
Blenman, KR | 1 |
Neal, JW | 1 |
Hwang, G | 1 |
Pultar, P | 1 |
San-Pedro Salcedo, M | 1 |
Engleman, E | 1 |
Lee, PP | 1 |
Malik, R | 1 |
Wakelee, HA | 1 |
1 other study available for talactoferrin alfa and Local Neoplasm Recurrence
Article | Year |
---|---|
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lactoferrin; Lung Neoplasms; Male; Middle Aged | 2014 |